Infusion product characteristics to predict response to tumor-infiltrating lymphocyte (TIL) therapy in metastatic melanoma (MM).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lilit Karapetyan, Kimberly Ward, Denise Kalos, Johannes Ali, Cheryl Cox, Joseph Markowitz, Andrew Scott Brohl, Zeynep Eroglu, Ahmad A. Tarhini, Nikhil I. Khushalani, Jane Messina, Kenneth Yee Tsai, John Mullinax, Jonathan S. Zager, Matthew Perez, Vernon K. Sondak, James J. Mule, Amod Sarnaik, Matthew Beatty, Shari Pilon-Thomas
Institution: Moffitt Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410818046